Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05270616

Robotic Versus Video-assisted Lobectomy/Segmentectomy for Lung Surgery

To compare the safety/efficacy of the robotic-assisted lobectomy/segmentectomy (RAL/S) with the video-assisted lobectomy/segmentectomy (VAL/S) for lung resection.

Video-assisted lobectomy/segmentectomy (VAL/S) for lung resection is divided into uniport group and multiple- port group.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Lung Diseases Respiratory Tract Diseases Surgery

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The Second Hospital of Shandong University

Jinan, Shandong, 250033, China

Location status: Recruiting

Location contact

Yunpeng Zhao, doctor

CONTACT

+8618766188692

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • good cardio- pulmonary function to tolerate surgery;
  • minimaly invasive surgery for lobectomy or segmentectomy or sleeve lobectomy;

Exclusion criteria

  • cardio- pulmonary function is not good enough to tolerate surgery;
  • huge tumor or extensive adhesion in thoracic cavity.

Treatment and study plan

Robotic surgery

Procedure

minimally invasive surgery using the Davinci robotic system

uniport surgery

Procedure

VATS minimally invasive surgery under the uniportal status

multiple- port surgery

Procedure

VATS minimally invasive surgery under the multiple- port status

Primary outcomes

  1. mortality

    Time frame: 30 days after surgery

    incidence rate

  2. conversion rate to open surgery

    Time frame: during surgery

    incidence rate

  3. postoperative complications

    Time frame: within 7 days after surgery

    incidence rate

  4. operation time

    Time frame: within 180 minutes

    minutes

  5. duration of hospitalization

    Time frame: within 7 days after surgery

    days

  6. days to tube removal

    Time frame: within 7 days after surgery

    days

  7. retrieved lymph node

    Time frame: within 1 days after surgery

    amount

  8. retrieved lymph node station

    Time frame: within 1 days after surgery

    amount

  9. short- term PFS

    Time frame: 3 years

    proportion

  10. short- term overall survival

    Time frame: 3 years

    proportion

Study contacts

Contact information is provided by the study sponsor or research team.

Xiaogang Zhao

CONTACT

[email protected]

+8617660080007

Yunpeng Zhao

CONTACT

[email protected]

18766188692

Sponsors and collaborators

Lead sponsor

The Second Hospital of Shandong University

Other

Registry information

Important dates

Study start
2020
Primary completion
2023
Study completion
2028
First posted
Mar 8, 2022
Registry last updated
Mar 8, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.